SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 94 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $503,672 | +104.8% | 77,369 | +168.3% | 0.00% | +100.0% |
Q4 2022 | $245,980 | +182.7% | 28,837 | +75.6% | 0.00% | 0.0% |
Q3 2022 | $87,000 | +14.5% | 16,425 | -8.1% | 0.00% | 0.0% |
Q2 2022 | $76,000 | -91.6% | 17,866 | -8.3% | 0.00% | -92.3% |
Q4 2020 | $903,000 | – | 19,484 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 4,012,903 | $15,168,773 | 7.77% |
Nextech Invest Ltd. | 1,910,029 | $7,219,910 | 2.19% |
K2 PRINCIPAL FUND, L.P. | 2,552,062 | $9,646,794 | 2.02% |
Charles Schwab Trust Co | 4,246,071 | $16,050,148 | 1.81% |
Sio Capital Management, LLC | 1,105,911 | $4,180,344 | 1.29% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,077,927 | $41,874,564 | 0.92% |
SECTORAL ASSET MANAGEMENT INC | 1,049,191 | $3,965,942 | 0.77% |
Orbimed Advisors | 9,240,887 | $34,930,553 | 0.74% |
RA Capital Management | 9,459,678 | $35,757,583 | 0.70% |
K2 PRINCIPAL FUND, L.P. | 688,900 | $2,604,042 | 0.55% |